Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus nalbuphine added to bupivacaine for bilateral intermediate cervical plexus block in thyroidectomy
PACTR202510614699556Phase 2Unknown
- Sponsor
- Mansoura University Faculty of Medicine
- Start
- Aug 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine, nalbuphine and bupivacaine in postoperative pain (3 arms), sponsored by Mansoura University Faculty of Medicine. Primary endpoint: Time to first analgesic request. Status: unknown.
02
Drugs
dexmedetomidinenalbuphinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202510614699556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510614699556.